Cholesterol-like molecules switch off the engine in cancer-targeting Natural Killer cells

September 18, 2017

Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.

The scientists, led by Ussher Assistant Professor in Immunometabolism at Trinity College Dublin, Dr David Finlay, have just published their findings in leading journal Nature Immunology. They report a previously unknown metabolic switch, which is essential for initiating the anti-tumour actions of Natural Killer cells.

Natural Killer (NK) cells are immune cells that play an important role in our defence against cancer, as they can directly kill tumour cells. Once activated, NK cells increase their uptake of cellular fuel, which is converted into energy by a biochemical engine. These engines and their fuel thus power the all-important tumour-killing machinery of the NK cells.

The new research shows that activated NK cells use a very different engine configuration to that observed in other immune cells and that the key factor that switches NK cells to this engine configuration is a protein called 'Srebp.' When the scientists used oxysterols to prevent this switch from occurring, the NK cells failed to kill tumour cells.

Dr David Finlay said: "The function of Srebp -- the key factor that controls the energy production in Natural Killer cells and thus fuels their activity -- is known to be blocked by cholesterol and cholesterol-like molecules, called oxysterols. Therefore, our findings reveal a previously unknown way by which the cancer-killing functions of Natural Killer cells can be disrupted."

As tumour cells can produce oxysterols and cholesterol levels tend to be higher in people with obesity, the scientists believe they may now have part of the explanation for why NK cells typically perform poorly in patients living with cancer and obesity.

"The next step is to investigate whether the functions of Natural Killer cells are indeed impaired in individuals with high cholesterol level, and whether cholesterol lowering interventions can restore NK cell function in these individuals," added Dr Finlay.
-end-


Trinity College Dublin

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.